Загрузка...
Understanding anti-leukemia responses to donor lymphocyte infusion
Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4203631/ https://ncbi.nlm.nih.gov/pubmed/25340010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28187 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|